2022
DOI: 10.21203/rs.3.rs-1285239/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Dietary resistant starch ameliorating lipopolysaccharide-induced inflammation associated with alteration in gut microbiome and glucagon-like peptide 1 signaling

Abstract: Background Consumption of resistant starch (RS) has been associated with various intestinal and systemic health benefits, but knowledge of its effects on intestinal health and inflammatory response in stressed birds is limited. Here, we examined how dietary RS supplementation modulated inflammatory severity induced by lipopolysaccharide (LPS) in meat ducks. Results LPS administration at 14, 16, and 18 d (chronic challenge) decreased body weight and glucagon-like peptide 1 receptor (GLP-1R) with higher intest… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Previous studies have revealed that administration of the prebiotic xylooligosaccharide (XOS) could promote a good bacterial composition that restores gut dysbiosis and improves kidney injury and dysfunction induced by HF (Sriwichaiin, Kittichotirat, Chunchai, Chattipakorn, & Chattipakorn, 2022;Wanchai et al, 2018). RS modulated gut microbiota dysbiosis by inducing a high relative proportion of Firmicutes and Bacteroidetes along with a decreased proportion of Proteobacteria, leading to a stronger intestinal microbiota fermentation capacity (Qin et al, 2022). A number of previous studies in a macrophage cell line (LAW264.7) demonstrated that supplementation with BR downregulated the production of TNFα, IL6, iNOS, and COX2 cytokines through the inhibition of the NF-κB pathway (Limtrakul, Yodkeeree, Pitchakarn, & Punfa, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have revealed that administration of the prebiotic xylooligosaccharide (XOS) could promote a good bacterial composition that restores gut dysbiosis and improves kidney injury and dysfunction induced by HF (Sriwichaiin, Kittichotirat, Chunchai, Chattipakorn, & Chattipakorn, 2022;Wanchai et al, 2018). RS modulated gut microbiota dysbiosis by inducing a high relative proportion of Firmicutes and Bacteroidetes along with a decreased proportion of Proteobacteria, leading to a stronger intestinal microbiota fermentation capacity (Qin et al, 2022). A number of previous studies in a macrophage cell line (LAW264.7) demonstrated that supplementation with BR downregulated the production of TNFα, IL6, iNOS, and COX2 cytokines through the inhibition of the NF-κB pathway (Limtrakul, Yodkeeree, Pitchakarn, & Punfa, 2015).…”
Section: Discussionmentioning
confidence: 99%